Female Sexual Dysfunction in Diabetes: Mechanisms, Diagnosis and Treatment

Curr Diabetes Rev. 2022;18(1):e171121198002. doi: 10.2174/1573399818666211117123802.

Abstract

Female sexual dysfunction (FSD) is an underinvestigated comorbidity of diabetes mellitus, often not evaluated in diabetes clinics. Diabetic women should be encouraged to talk about this topic by their diabetologist, because these problems could be comorbid to cardio-metabolic alterations, as it happens in the male counterpart. This review summarizes evidence on sexual dysfunction characteristics in diabetic women, exploring possible underlying pathogenic mechanisms. The role of hypoglycemic drugs in this context was also evaluated. To date, no specific questionnaire has been designed for the assessment of sexual dysfunctions in diabetic female patients but the use of colour-doppler ultrasound of clitoral arteries has been highlighted as a useful tool for the assessment of cardiovascular risk in these women. Similarly, no specific guidelines are available for the treatment of FSD in the diabetic population but patients should be supported to have a healthy lifestyle and, in the absence of contraindications, can benefit from already approved treatments for FSD.

Keywords: Diabetes mellitus; cardio-metabolic alterations; female sexual dysfunction; gender medicine; hypoactive sexual desire disorder; hypoglycemic treatment.

Publication types

  • Review

MeSH terms

  • Diabetes Mellitus*
  • Female
  • Humans
  • Male
  • Sexual Dysfunction, Physiological* / diagnosis
  • Sexual Dysfunction, Physiological* / etiology
  • Sexual Dysfunction, Physiological* / therapy
  • Sexual Dysfunctions, Psychological*
  • Surveys and Questionnaires